US pharmaceutical firm Pfizer (PFE) has sold off its remaining stake in Sensodyne and Panadol maker Haleon (HLN.L) for around £2.5 billion. Haleon has agreed to buy back 44 million shares from Pfizer ...

Sensodyne toothpaste maker Haleon hailed an ‘important milestone’ as an independent company after US pharma giant Pfizer sold its remaining stake in the business. Shares in the consumer health ...

raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne toothpaste. The ...

Pfizer is wrapping up its lucrative goodbye to Haleon, raising approximately $3.3 billion by offloading its remaining 7.3% ...

Wall Street's major averages closed in the green on Friday, and the benchmark S&P 500 (SP500) snapped a four-week losing streak after U.S. President Donald Trump said there might be some "flexibility" ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

No other corporate actions details are available.

The new company – which has achieved the largest London listing in a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers ...

From award-winning writing and photography to binge-ready videos to electric live events, GQ meets millions of modern men where they live, creating the moments that create conversations.

The shares were 330p when Pfizer spun off its original 32% stake in the Sensodyne business in 2022. IT infrastructure services business Softcat jumped 12% or 201p to 1824p after reporting half ...